文献速递泌尿生殖与妇科肿瘤放疗

PAF1通过抑制IER5转录减弱宫颈癌放射敏感性的新作用

Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription.
PubMed 文献 · Radiat Oncol · 2020-05-29

该研究探讨PAF1在宫颈癌放疗中调控IER5表达的机制。PAF1在宫颈癌细胞中高表达,敲低PAF1可增加IER5表达、降低细胞活力并提高放疗后凋亡率。PAF1通过增强子结合促进Pol II在启动子近端暂停从而抑制IER5转录,提示PAF1可能是克服宫颈癌放射抵抗的潜在靶点。

要点

  • PAF1在宫颈癌细胞中高表达,与IER5低表达相关。
  • 敲低PAF1增加IER5表达并提高放疗后凋亡率。
  • PAF1通过增强子结合抑制IER5转录。

核心结论

  • PAF1通过抑制IER5转录减弱宫颈癌放射敏感性,至少部分通过调控其增强子实现。
  • PAF1可能是克服宫颈癌患者放射抵抗的潜在治疗靶点。

研究设计与样本

  • 基础实验研究,使用Siha和Hela宫颈癌细胞系。
  • 采用western blotting、免疫组化、qRT-PCR、免疫荧光、siRNA敲低、CCK-8、流式细胞术、染色质免疫沉淀和CRISPR/Cas9增强子敲除等技术。

主要发现

  • PAF1在宫颈癌细胞中高表达,高表达PAF1的细胞核中IER5表达相对较低。
  • 敲低PAF1的Siha和Hela细胞IER5表达增加、细胞活力降低、放疗后凋亡率升高。
  • 同时敲低PAF1和IER5对凋亡细胞比例影响不大。
  • PAF1通过促进Pol II在启动子近端区域暂停来阻碍IER5转录,主要归因于PAF1在增强子处的结合。

临床怎么用

  • PAF1可能作为克服宫颈癌放射抵抗的潜在靶点,但尚未进入临床转化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiosensitivity is limited in cervical cancer (CC) patients due to acquired radiation resistance. In our previous studies, we found that immediate-early response 5 (IER5) is upregulated in CC cells upon radiation exposure and decreases cell survival by promoting apoptosis. The details on the transcriptional regulation of radiation-induced IER5 expression are unknown. Studies in recent years have suggested that Pol II-associated factor 1 (PAF1) is a pivotal transcription factor for certain genes "induced" during tumor progression. In this study, we investigated the role of PAF1 in regulating IER5 expression during CC radiotherapy. METHODS: PAF1 expression in CC cells was measured by western blotting, immunohistochemistry, and qRT-PCR, and the localization of PAF1 and IER5 was determined by immunofluorescence. The effect of PAF1 and IER5 knockdown by siRNA in Siha and Hela cells was studied by western blotting, qRT-PCR, CCK-8 assay, and flow cytometry. The physical interaction of PAF1 with the IER5 promoter and enhancers was confirmed using chromatin immunoprecipitation and qPCR with or without enhancers knockout by CRISPR/Cas9. RESULTS: We confirmed that PAF1 was highly expressed in CC cells and that relatively low expression of IER5 was observed in cells with highly expressed PAF1 in the nucleus. PAF1 knockdown in Siha and Hela cells was associated with increased expression of IER5, reduced cell viability and higher apoptosis rate in response to radiation exposure, while simultaneous PAF1 and IER5 knockdown had little effect on the proportion of apoptotic cells. We also found that PAF1 hindered the transcription of IER5 by promoting Pol II pausing at the promoter-proximal region, which was primarily due to the binding of PAF1 at the enhancers. CONCLUSIONS: PAF1 reduces CC radiosensitivity by inhibiting IER5 transcription, at least in part by regulating its enhancers. PAF1 might be a potential therapeutic target for overcoming radiation resistance in CC patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zheng JJ, He Y, Liu Y, et al. Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription. Radiat Oncol. 2020. PMID: 32471508. doi:10.1186/s13014-020-01580-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。